Bristol Myers Squibb announces that the European Medicines Agency has validated its application for Opdivo + Yervoy as first-line treatment for adult patients with metastatic colorectal cancer with...
Related Keywords
Bristol Myers Squibb , Dana Walker , European Medicines Agency , Global Head , Genitourinary Cancers , Bristol Myers , Markets ,
comparemela.com © 2020. All Rights Reserved.